Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
34.08
-0.10 (-0.29%)
At close: Sep 10, 2026, 4:00 PM EDT
34.07
-0.02 (-0.04%)
After-hours: Sep 10, 2026, 7:30 PM EDT
Cogent Biosciences Market Cap
Cogent Biosciences has a market cap or net worth of $5.92 billion as of September 10, 2026. Its market cap has increased by 230.11% in one year.
Market Cap
5.92B
Enterprise Value
5.37B
1-Year Change
230.11%
Ranking
Category
Stock Price
$34.08
ChartMarket Cap Chart
Since July 10, 2020, Cogent Biosciences's market cap has increased from $124.27M to $5.92B, an increase of 4,659.94%. That is a compound annual growth rate of 86.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 5.92B | 9.47% |
| Dec 31, 2025 | 5.40B | 527.16% |
| Dec 31, 2024 | 861.60M | 70.14% |
| Dec 29, 2023 | 506.41M | -37.32% |
| Dec 30, 2022 | 807.97M | 136.30% |
| Dec 31, 2021 | 341.92M | -2.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Scholar Rock Holding | 6.74B |
| CG Oncology | 6.62B |
| Mirum Pharmaceuticals | 6.55B |
| Travere Therapeutics | 6.15B |
| Oruka Therapeutics | 6.13B |
| Dianthus Therapeutics | 6.05B |
| Xenon Pharmaceuticals | 5.79B |
| PTC Therapeutics | 5.78B |